{"name":"ELASMOGEN LIMITED","company_number":"SC467513","status":"Active","type":"Private Limited Company","incorporated":"2014-01-15","dissolved":null,"registered_office":"Liberty Building, Foresterhill, Aberdeen, AB25 2ZP","postcode":"AB25 2ZP","sic_codes":[{"code":72110,"description":"Research and experimental development on biotechnology"}],"principal_activity":null,"previous_names":[{"name":"PACIFIC SHELF 1760 LIMITED","changed_on":"2014-02-05"}],"warnings":[],"accounts":{"category":"Full","year_end":"31 January","last_made_up_to":"2026-01-31","next_due":"2027-10-31"},"employees":null,"financials":[{"financial_date":"2017-01-31","cash":170095},{"financial_date":"2016-01-31","cash":1299},{"financial_date":"2015-01-31","cash":1}],"officers":{"current":4,"resigned":10,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":0,"outstanding":0},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Elasmogen is a credible, investor-backed next-generation biologics platform with differentiated soloMER assets in oncology and inflammation, but it remains pre-commercial and dependent on external capital. With £2.31m cash against a £1.68m annual loss, management has roughly 16–18 months of runway and must convert scientific differentiation into partnered programmes, milestone funding, and clinical proof before the next financing window. The priority is disciplined capital allocation around lead assets, pharma validation, and non-dilutive funding, with board/key-person continuity and IP/manufacturing execution managed as critical risks.","website":"https://elasmogen.com/","links":{"page":"https://www.companiesintheuk.co.uk/ltd/elasmogen","people":"https://www.companiesintheuk.co.uk/company/elasmogen/people","filing_history":"https://www.companiesintheuk.co.uk/company/elasmogen/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/SC467513","financials":"https://www.companiesintheuk.co.uk/company/elasmogen/financial","control":"https://www.companiesintheuk.co.uk/company/elasmogen/control","ai_analysis":"https://www.companiesintheuk.co.uk/company/elasmogen/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/elasmogen"}